Conference call to Announce Initial Data from Phase 1/2 Clinical Trial of FLX475 in Multiple Cancer Indications Nov 16, 2020 at 8:30 AM EST Click here for webcast Supporting Materials RAPT Therapeutics Initial Data Readout for FLX475 1.6 MB
